Literature DB >> 21735237

Synchronous bilateral neuroendocrine ductal carcinoma in situ.

Hisae Honami1, Keiichi Sotome, Goi Sakamoto, Hisami Iri, Yoichi Tanaka, Shigeru Fukamachi, Kyoei Morozumi.   

Abstract

Neuroendocrine ductal carcinoma in situ (NE-DCIS) is a breast malignancy that has characteristic clinicopathological features and can, therefore, be regarded as a distinct variant of DCIS. The patient was a 54-year-old premenopausal woman with hemorrhagic nipple discharge in her left breast. Magnetic resonance imaging and ultrasound (US) images of the left breast showed mass-like lesions, while concurrent images of the right breast showed non-mass-like lesions. These findings suggested the presence of both benign and malignant tumors. Pathological findings from US-guided core-needle biopsy of the left mass were highly suspicious of a malignant tumor. Excisional biopsy of both breasts was performed. We could define the diagnosis of breast cancer by the second opinion on pathological diagnosis. The tumor cells showed histological characteristics of NE-DCIS. Bilateral breast lesions had histopathological similarities and were composed of predominantly solid growth of carcinoma cells, frequently with well-developed vascular structures, in mammary ducts and ductules. Carcinoma cells were polygonal or occasionally spindle shaped and had fine-granular, relatively eosinophilic cytoplasm. The nuclei of these cells showed round to ovoid in shape and fine-granular chromatin pattern. There was not any invasive component, as confirmed by careful histological examination. Thus, additional immunohistochemical stainings for NE markers (chromogranin A and synaptophysin) were performed. Staining statuses of these markers were positive in almost all tumor cells from both breasts. Both tumors were therefore diagnosed as NE-DCIS. To our knowledge, this case is the first report of NE-DCIS diagnosed synchronously in both breasts.

Entities:  

Mesh:

Year:  2011        PMID: 21735237     DOI: 10.1007/s12282-011-0278-1

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

Review 1.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

2.  Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Authors:  Fernando A Angarita; Jorge L Rodríguez; Eugenio Meek; Jesus O Sánchez; Mauricio Tawil; Lilian Torregrosa
Journal:  World J Surg Oncol       Date:  2013-06-05       Impact factor: 2.754

3.  Synchronous bilateral solid papillary carcinomas of the breast.

Authors:  Noriko Yoshimura; Shigeru Murakami; Mayumi Kaneko; Akio Sakatani; Naoki Hirabayashi; Wataru Takiyama
Journal:  Case Rep Surg       Date:  2013-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.